KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 151 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $131,000 | +4266.7% | 29,111 | +6080.7% | 0.01% | – |
| Q1 2022 | $3,000 | -62.5% | 471 | -62.6% | 0.00% | – |
| Q4 2021 | $8,000 | -87.3% | 1,258 | -88.3% | 0.00% | -100.0% |
| Q3 2021 | $63,000 | +2000.0% | 10,774 | +3503.3% | 0.00% | – |
| Q1 2021 | $3,000 | -85.0% | 299 | -78.3% | 0.00% | -100.0% |
| Q3 2020 | $20,000 | -67.2% | 1,379 | -57.1% | 0.00% | -71.4% |
| Q2 2020 | $61,000 | +190.5% | 3,213 | +194.5% | 0.01% | -22.2% |
| Q1 2020 | $21,000 | +950.0% | 1,091 | +305.6% | 0.01% | +800.0% |
| Q2 2019 | $2,000 | +100.0% | 269 | +232.1% | 0.00% | – |
| Q3 2018 | $1,000 | -50.0% | 81 | -22.9% | 0.00% | -100.0% |
| Q2 2018 | $2,000 | -33.3% | 105 | -68.6% | 0.00% | -50.0% |
| Q4 2017 | $3,000 | – | 334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
| Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
| Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
| Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
| Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
| Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
| Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
| Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
| EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |